July 2006: Canadian Manufacturer Adds Warning to Vial for Neuromuscular Blocking Agent
Hospira is a member of a collaborative initiative led by ISMP Canada to enhance the labelling and packaging of neuromuscular blocking agents in Canada. Pursuant to a consensus on ideal packaging and labelling features for these drugs, Hospira has quickly revised its vial ferrule and cap to include the following content: “Warning: Paralyzing Agent”. ISMP Canada will continue to provide updates on this important collaborative initiative, a first in Canada.
